Study Stopped
FDA requested changes to study prior to continuation of enrollment
Pro-2-Cool Pivotal Trial II
An Assessment of Clinical Efficacy of Hypothermic Therapy Following Mild Traumatic Brain Injury (mTBI) in the Adolescent Athlete as Compared to an Untreated Active Control Population
1 other identifier
interventional
72
1 country
2
Brief Summary
This study is being conducted to quantify the clinical safety and efficacy of head and neck cooling, using the Pro-2-Cool device, when applied after mTBI injury sustained by adolescents aged 12-21 years, participating in sporting activities.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2025
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 20, 2025
CompletedFirst Submitted
Initial submission to the registry
April 14, 2025
CompletedFirst Posted
Study publicly available on registry
April 16, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedJuly 25, 2025
July 1, 2025
12 months
April 14, 2025
July 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
SCAT-5 change from baseline to the post-72 hour follow-up visit measurement
Sport Concussion Assessment Tool 5th edition (SCAT-5) is the current standard of practice assessment tool used at the time of injury to diagnose an mTBI.
Baseline to 72-hour follow-up
Study Arms (2)
Pro-2-Cool Device
EXPERIMENTALStandard of Care
NO INTERVENTION"Brain rest"
Interventions
The Pro-2-Cool Device is a non-invasive hypothermic therapy ("cold therapy") device that provides localized cooling of the head and neck. Water and isopropyl alcohol cooled to 6°C by the chiller assembly circulate through the cooling garment to create conductive heat transfer from the scalp and carotid arteries, thus achieving cooling of the brain.
Eligibility Criteria
You may qualify if:
- Males and females ages 12 - 21 years
- Initial provider visit is within 8 days of mTBI injury
- Confirmed mTBI diagnosis from sporting activities
- In generally good health as confirmed by medical history and as determined by site investigator
- Has a symptom score of at least 7 (analogous of the SCAT5 symptoms score)
- Has informed consent obtained per protocol and as required per IRB
You may not qualify if:
- Cleared to return to play during initial visit
- Suffers a serious TBI as evidenced by worsening symptoms, specifically:
- GCS \<14 2.2. Seizure 2.3. Hospitalization 2.4. Existing positive diagnostic testing which include radiology scans that indicate brain bleed 2.5. Slurred speech, which has not resolved within 72 hours of mTBI injury
- Sustains another head or neck injury at the time of mTBI injury which requires medical treatment
- History of a serious medical or psychiatric disorder that include:
- Suicide attempt in the last 6 months 4.2. Unmanaged depression or anxiety 4.3. Hospitalization in the last 6 months for psychiatric treatment
- History of Reynaud's disease or phenomenon, cold agglutinin disease, cryoglobulinemia, or cryofibrinogenemia
- Previously diagnosed with a cerebrovascular disorder
- Is unable to understand the study requirements or the informed consent
- Currently enrolled in another investigational research study that may confound the results of this study
- Non-English speaking subjects and parents/legal guardians
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- TecTraum Inc.lead
Study Sites (2)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Akron Children's Hospital
Akron, Ohio, 44308, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Brian Reilly, MD
Children's Hospital Medical Center of Akron
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 14, 2025
First Posted
April 16, 2025
Study Start
February 20, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
July 25, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share